The global fight against Hepatitis C has transformed significantly over the past decade, with direct-acting antiviral (DAA) medicines offering higher cure rates, shorter treatment durations, and improved patient outcomes. Among these breakthrough therapies, Sofosbuvir Tablets have become one of the most widely prescribed antiviral medicines for Hepatitis C treatment. As healthcare systems expand access to affordable antiviral medicines, pharmaceutical companies, government procurement agencies, hospitals, NGOs, and international distributors continue to seek dependable Sofosbuvir Tablets Manufacturers capable of delivering high-quality products that comply with international quality standards.
Choosing the right manufacturing partner is critical for pharmaceutical businesses serving regulated and semi-regulated markets. Buyers require consistent product quality, WHO-GMP certified manufacturing, comprehensive regulatory documentation, reliable production capacity, and timely global delivery.
Wellona Pharma is a trusted Sofosbuvir Tablets Manufacturer and Supplier, offering WHO-GMP certified manufacturing, advanced quality assurance systems, contract manufacturing, private labeling, and pharmaceutical exports to more than 86 countries worldwide. Our manufacturing excellence enables global healthcare providers to access high-quality antiviral medicines through reliable supply partnerships.
Sofosbuvir is a direct-acting antiviral (DAA) medicine used as part of combination therapy for the treatment of chronic Hepatitis C Virus (HCV) infection. Treatment regimens vary depending on viral genotype, patient condition, and local clinical guidelines. Healthcare professionals prescribe Sofosbuvir in combination with other antiviral medicines to achieve sustained virological response (SVR), commonly referred to as a cure.
Sofosbuvir-based therapy has significantly improved Hepatitis C management due to:
Because of these clinical advantages, Sofosbuvir remains an essential product in antiviral medicine portfolios worldwide.
As a leading pharmaceutical exporter, Wellona Pharma manufactures Sofosbuvir tablets using advanced pharmaceutical technology within WHO-GMP certified manufacturing facilities.
Our Tablet Manufacturing Division is equipped with:
Our facilities are designed to consistently manufacture high-quality antiviral medicines that meet international pharmaceutical standards.
We manufacture Sofosbuvir tablets according to international market requirements.
Common strengths include:
Customized packaging, labeling, and branding are available depending on country-specific regulatory requirements and customer preferences.
Quality manufacturing is the foundation of successful pharmaceutical exports.
Our WHO-GMP certified manufacturing processes include:
These systems help ensure every production batch delivers consistent quality and performance.
Every batch of Sofosbuvir tablets undergoes carefully controlled manufacturing stages.
Only pharmaceutical-grade Active Pharmaceutical Ingredients (API) sourced from approved vendors are accepted after comprehensive quality evaluation.
Incoming raw materials undergo:
Materials are approved only after meeting strict internal quality standards.
Validated granulation techniques ensure:
Modern tablet presses maintain:
Film coating improves:
Finished tablets are packed under GMP-controlled conditions using automated packaging systems.
Every production batch undergoes extensive quality testing before commercial release.
Testing includes:
Quality assurance personnel review complete batch documentation before approval.
Learn more about our Quality Control & Quality Assurance systems.
International buyers require different packaging formats depending on market regulations.
Wellona Pharma offers:
Packaging artwork can be customized according to customer branding and local regulatory requirements.
Wellona Pharma exports pharmaceutical products to more than 86 countries, serving:
Our experienced export department manages documentation, logistics coordination, and shipment compliance for international customers.
Successful pharmaceutical registration requires comprehensive technical documentation.
We provide:
These documents simplify product registration and import procedures in multiple international markets.
Many pharmaceutical companies rely on contract manufacturing to expand their product portfolios efficiently.
Our Contract Manufacturing and Third Party Manufacturing services include:
These services enable pharmaceutical companies to launch high-quality antiviral products under their own brands.
Global pharmaceutical companies choose Wellona Pharma because we offer:
Our integrated manufacturing and export capabilities make us a trusted partner for pharmaceutical businesses worldwide.
The global burden of Hepatitis C remains a major public health concern. Governments and healthcare organizations continue investing in screening programs, treatment access, and elimination initiatives.
This increasing demand drives procurement by:
Reliable manufacturers capable of maintaining uninterrupted production are essential to support these global healthcare initiatives.
For additional information regarding Hepatitis C management, visit the World Health Organization – Hepatitis C.
Supplying antiviral medicines globally requires more than manufacturing expertise.
Our international supply chain includes:
This integrated approach enables uninterrupted medicine availability for customers across multiple international markets.
At Wellona Pharma, we believe successful pharmaceutical partnerships are built on trust, transparency, and consistent performance.
We work closely with:
By combining advanced manufacturing with export expertise, we help customers strengthen their market presence while ensuring dependable medicine supply.
Yes. We manufacture Sofosbuvir 400 mg tablets according to international quality standards and customer requirements.
Yes. Our production facilities follow WHO-GMP guidelines with validated manufacturing processes and stringent quality control systems.
Yes. We offer OEM manufacturing, private labeling, customized packaging, and branding solutions for pharmaceutical companies worldwide.
We export pharmaceutical products to more than 86 countries across Africa, Asia, the Middle East, CIS nations, Latin America, and other international markets.
We provide COA, COPP, CTD/ACTD dossiers, stability studies, Free Sale Certificates, Batch Manufacturing Records, MSDS, and other registration documents required by importing countries.
If your organization is searching for a reliable Sofosbuvir Tablets Manufacturer and Supplier with WHO-GMP certified facilities, international export experience, and comprehensive regulatory support, Wellona Pharma is your trusted pharmaceutical manufacturing partner.
Visit our Tablet Product Category to explore our complete range of tablet formulations, or contact our team today to discuss bulk procurement, contract manufacturing, third-party manufacturing, private labeling, and global pharmaceutical export opportunities.